Search

Search Results
Results 26291 - 26300 of 26413 for AIDS
  • DBL Pentamidine Isethionate
    Drug - 20 Jun 2022
    Consumer Medicine Information (CMI) about DBL Pentamidine Isethionate intended for persons living in Australia.
  • Combating Parkinson’s disease, the second most common neurodegenerative disease
    White Paper - 30 May 2022
    Parkinson’s disease is the second most common neurodegenerative disease. As it continues to affect more and more people, there’s massive demand for continued and new research into novel and...
  • Zykadia
    Drug - 5 Apr 2022
    Consumer Medicine Information (CMI) about Zykadia intended for persons living in Australia.
  • Analysis of additives in diet soft drinks with green chemistry
    White Paper - 23 Feb 2022
    Discover more about the analysis of additives in diet soft drinks with green chemistry.
  • Lorviqua
    Drug - 23 Dec 2021
    Consumer Medicine Information (CMI) about Lorviqua intended for persons living in Australia.
  • Anti-idiotypic antibodies: How are they used in drug development?
    White Paper - 10 Nov 2021
    Anti-idiotypic antibodies, often known as anti-drug antibodies, are important references for immunogenicity analysis. They are incredibly useful in pharmacokinetics research. ACROBiosystems offers a...
  • Panamax
    Drug - 3 Nov 2021
    Consumer Medicine Information (CMI) about Panamax intended for persons living in Australia.
  • Rukobia Tablets
    Drug - 5 Aug 2021
    Consumer Medicine Information (CMI) about Rukobia Tablets intended for persons living in Australia.
  • Betmiga
    Drug - 21 Jul 2021
    Consumer Medicine Information (CMI) about Betmiga intended for persons living in Australia.
  • Suboxone Film
    Drug - 12 Apr 2021
    Consumer Medicine Information (CMI) about Suboxone Film (Buprenorphine Hydrochloride + Naloxone Hydrochloride Dihydrate) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback